Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis Mareike SchadJürgen John Original Paper 19 December 2010 Pages: 127 - 144
Cost-effectiveness of treatment with etanercept for psoriasis in Sweden Christopher KnightJosephine MauskopfRobert Boggs Original Paper 06 March 2011 Pages: 145 - 156
Malpractice liability, technology choice and negative defensive medicine Eberhard Feess Original Paper 11 January 2011 Pages: 157 - 167
Decision-making in general practice: the effect of financial incentives on the use of laboratory analyses Siri Fauli Munkerud Original Paper 07 January 2011 Pages: 169 - 180
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam Steven J. EdwardsSarah WordsworthMike J. Clarke Original Paper 18 January 2011 Pages: 181 - 192
Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence Oliver ReichCornelia WeinsMagdalena Thöni Original Paper 03 February 2011 Pages: 193 - 202
Defining care products to finance health care in the Netherlands Machiel WesterdijkJoost ZuurbierSarah Prins Original Paper Open access 25 February 2011 Pages: 203 - 221